A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Recruiting · NCT07332000 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-09-15 | NCT07332000 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Candel Therapeutics, Inc. | 6 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Academic Urology and Urogynecology of Arizona | Peoria | United States | 1 |
| Chesapeake Urology Research Associates | Towson | United States | 11 |
| Colorado Clinical Research | Lakewood | United States | 20 |
| Sheldon Freedman, MD Ltd. | Las Vegas | United States | 1 |
| START Carolinas | Myrtle Beach | United States | 3 |
| Summit Health | Saddle Brook | United States | 1 |
| Urology Associates | Littleton | United States | 1 |